OpGen (LTS:0A8L) ROE % Adjusted to Book Value : -27.78% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is OpGen ROE % Adjusted to Book Value?

OpGen's ROE % for the quarter that ended in Sep. 2023 was -340.82%. OpGen's PB Ratio for the quarter that ended in Sep. 2023 was 12.27. OpGen's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 was -27.78%.

OpGen ROE % Adjusted to Book Value Historical Data

The historical data trend for OpGen's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OpGen ROE % Adjusted to Book Value Chart

OpGen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-96.99

-137.68

OpGen Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-241.78	-352.92	-139.78	-87.29	-27.78

Competitive Comparison of OpGen's ROE % Adjusted to Book Value

For the Medical Devices subindustry, OpGen's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OpGen's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OpGen's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where OpGen's ROE % Adjusted to Book Value falls into.

OpGen ROE % Adjusted to Book Value Calculation

OpGen's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-152.82%	/	1.11
	=	-137.68%

OpGen's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-340.82%	/	12.27
	=	-27.78%

OpGen ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of OpGen's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

OpGen (LTS:0A8L) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OpGen Inc (LTS:0A8L) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

OPGN:USA 650:Germany

Address

9717 Key West Avenue, Suite 100, Rockville, MD, USA, 20850

Website

https://www.opgen.com

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

OpGen (LTS:0A8L) Headlines

No Headlines